EBV (Epstein-Barr virus) VCA IgG
Material: Blood
Test price: PLN 38.00
Waiting time for results: result after 3 working days
Reservation:
Test price: PLN 38.00
Waiting time for results: result after 3 working days
Reservation:
- Check the opening hours of the collection point and where an appointment is required.
Preparation for the examination
General
- The material for testing is blood.
- The patient does not need to fast. It is recommended to drink a glass of water approximately 30 minutes before the examination.
Description
Epstein-Barr virus (EBV) is one of the most common human herpes viruses. The virus is transmitted through saliva, respiratory droplets, and also through blood transfusions
and organ transplants. Epstein-Barr virus causes infectious mononucleosis (Pfeiffer's disease), an illness characterized by fever, sore throat, and lymphadenopathy, often accompanied by enlargement of the liver and spleen, and rarely by a rash. When infection first occurs in childhood, it is usually asymptomatic.
The primary goal of EBV diagnosis in people with healthy immune systems is to distinguish between recent and past infections. Various serological methods are used for this purpose.
The immune system of a healthy person can quickly combat viral reactivation.
However, in individuals with compromised immune systems (e.g., those undergoing immunosuppressive therapy after organ transplantation or infected with HIV), EBV can spread uncontrollably and cause severe lymphoproliferative disorders.
The immune response to EBV infection is characterized by the production of antibodies against EBV antigens: viral capsid antigen (VCA), nuclear antigen (EBNA), and early antigen (EA).
and organ transplants. Epstein-Barr virus causes infectious mononucleosis (Pfeiffer's disease), an illness characterized by fever, sore throat, and lymphadenopathy, often accompanied by enlargement of the liver and spleen, and rarely by a rash. When infection first occurs in childhood, it is usually asymptomatic.
The primary goal of EBV diagnosis in people with healthy immune systems is to distinguish between recent and past infections. Various serological methods are used for this purpose.
The immune system of a healthy person can quickly combat viral reactivation.
However, in individuals with compromised immune systems (e.g., those undergoing immunosuppressive therapy after organ transplantation or infected with HIV), EBV can spread uncontrollably and cause severe lymphoproliferative disorders.
The immune response to EBV infection is characterized by the production of antibodies against EBV antigens: viral capsid antigen (VCA), nuclear antigen (EBNA), and early antigen (EA).
Preparation and development of material (applies only to contractors)
27
VCA, Ebstein virus - Barr, virus capsid antigen, Mononucleosis.
